The Beat by unknown
Discovery consists of seeing what everybody has seen and thinking what nobody has thought. 
Albert Szent-Györgyi (1893–1986)
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California Enacts
Safe Cosmetics Act
Californians frustrated with what they con-
sider the FDA’s loose control over cosmetic
safety have taken matters into their own
hands with the country’s first state cosmetics
regulatory act, which takes effect in January
2007. The California Safe Cosmetics Act of
2005 will require manufacturers to report
the use of potentially hazardous ingredients
to the state Department of Health Services
(DHS), which in turn will alert consumers.
The DHS has the authority to investigate
whether the product could be toxic under
normal use and to require that manufactur-
ers submit health effects data. Manufacturers
that continue marketing products deemed
unsafe in California could face legal action.
“The legislation’s sponsors believe that
the basis of the law is the public’s right to
know,” says Kevin Reilly, DHS deputy
director of prevention services. The new law
uses the list of toxicants drawn up under
California’s Proposition 65, which mandates
that the governor publish a list, updated at
least yearly, of chemicals that are known to
the state of California to cause cancer, birth
defects, or other reproductive harm. 
Although the new act applies only in
California, its effects are likely to reverberate
nationwide. Consumer advocates predict
that manufacturers seeking to avoid negative
publicity will remove, rather than report,
suspect ingredients. Those formulas would
then be marketed coast to coast. 
Impetus for the law stems from con-
sumers’ concerns over long-term exposure to
certain cosmetic ingredients. Cosmetic use
has not been linked to chronic illnesses, but
some products do contain carcinogens (such
as formaldehyde, used in nail treatments),
teratogens (such as lead acetate, used in two
hair dyes), and other reproductive toxicants
(such as di-n-butyl phthalate, used in nail
treatments and dandruff shampoos). 
Studies in recent years have shown that
humans absorb and inhale sometimes sur-
prisingly high levels of toiletry ingredients.
In the November 2005 issue of EHP, a team
led by Susan M. Duty of the Harvard School
of Public Health demonstrated that urine
concentrations of phthalate metabolites
increased by 33% with each personal care
product—hair gel or spray, lotion, deodor-
ant, cologne, aftershave—that subjects used.
Historically, cosmetics safety has been in
the hands of manufacturers; the FDA re-
quires no premarket testing. Each year, an
expert panel convened by the industry-funded
Cosmetic Ingredient Review (CIR) identifies
priority ingredients for which it conducts lit-
erature reviews and analyses to determine
safety. The panel—made up of independent
academic researchers and representatives
from industry, consumer interests, and the
FDA—has declared 9 of the 1,286 ingredi-
ents reviewed since 1976 unsafe for normal
cosmetic use. But manufacturers are not
obligated to eliminate any ingredients—at
least one ingredient identified as unsafe by
CIR, hydroxyanisole, is still used.
Safety advocates see evidence of any
harm in any use as reason enough for a ban.
“Ingredients suspected of causing cancer
shouldn’t be used in cosmetics,” says spokes-
man Kevin Donegan of the Breast Cancer
Fund, a San Francisco–based nonprofit that
promoted the California bill.
F. Alan Andersen, director and scientific
coordinator of CIR, counters that the dose
creates the danger. “We don’t subscribe to
the notion that if there’s ever an adverse
effect, [a chemical] must not be in a prod-
uct people use,” he says. “It doesn’t make
sense to us to apply the precautionary prin-
ciple. Instead, we use a risk assessment
approach, and the wide margins of safety
that we have found for chemicals such as
phthalates using this approach assure us that
actual use of cosmetics is safe.”
The law drew fierce opposition from
individual companies and the Cosmetic,
Toiletry, and Fragrance Association (CTFA)
as it worked its way through the California
legislature. “CTFA supports strong federal
regulation by the FDA,” says Kathleen
Dezio, executive vice president of public
affairs and communications for the associa-
tion. “For this reason, CTFA has generally
opposed state-specific legislation that would
undermine this national approach and lead
to an unworkable state-by-state patchwork
of rules . . . or unjustified, extreme require-
ments that are well beyond those placed on
any other category of food, beverages,
drugs, or consumer products.” She adds
that CTFA has met with the DHS and
“pledged our cooperation in accomplishing
the requirements” of the law.
Some manufacturers have already ceded
to public pleas for safer products. In the past
two years, almost 350 of them signed a
pledge promoted by the Campaign for Safe
Cosmetics, a coalition of health and envi-
ronmental groups, to use no chemicals
linked to cancer or birth defects. Industry
leaders L’Oréal and Revlon broke new
ground last year when they promised that
products they sold in the United States
would meet more stringent European Union
standards. In 2004 Europe enacted a ban on
suspected carcinogens, mutagens, and repro-
ductive toxicants in personal care products. 
“We’re definitely seeing a shift in the
attitude of manufacturers,” Donegan
says. “They’re starting to see the benefits
of removing anything that could cause
cancer.” –Cynthia Washam
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A safer smooch. California recently enacted legislation that will require manufacturers to report
potentially hazardous ingredients used in cosmetic and personal care products.
LEGISLATIONNow Broadcasting: green.tv 
green.tv, the world’s first Internet-based
broadband channel dedicated to environmental
issues, started broadcasting in March 2006 from its
website at http://www.green.tv/. The
channel, developed with support
from UNEP, is also available
as a podcast on iTunes.
green.tv will carry films
from around the world,
produced by NGOs,
community film makers,
public sector agencies, and
environmentally minded
corporations. The site
features seven subchannels
focused on air, land, water,
climate change, people,
species, and technologies.
Each subchannel will run a feature film, a news
item, and a story for children. The channel’s first
offerings include films from Water Aid, the Sierra
Club, the Eden Project, the Women’s Environment
Network, Farm Africa, and others.
UNEP Promotes Sustainable
Building and Construction 
In February 2006 UNEP announced the launch of
the Sustainable Building and Construction
Initiative to promote environmentally friendly
practices in the construction industry. Three of the
world’s largest construction companies—Lafarge,
Skanska, and Arcelor—have signed on to the
effort. The construction sector employs over 100
million people worldwide and contributes 10% of
the global gross domestic product. Yet the industry
also plays a serious role in problems such as climate
change, waste generation, and depletion of
natural resources. The new initiative will address
these issues, and also lobby for laws and building
standards to support sustainable practices.
Pediatric Environmental
Health in Argentina 
WHO statistics show that approximately 33% of
diseases affecting children under age 5 are linked
to environmental risk factors. To address this
threat, the Argentine and Buenos Aires
governments have set up new “pediatric
environmental health
units” in Buenos Aires and
several provinces of
Argentina. The units are
made up of pediatricians,
nurses, social workers,
teachers, and others who
work as a team to uncover
and remediate risk factors
in children’s environments,
often at the request of a
referring physician. The
units have the authority to
work with schools, public works, and
neighborhood residents if they believe a specific
hazard exists. The units will also train other
professionals within the hospitals where they are
based and conduct research on child
environmental health issues.
Forum
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Tanning Trippers
Get UV High
It has long been suspected that cutaneous
endorphins are produced during exposure
to UV light. Now research published in the
April 2006 issue of the Journal of the Amer-
ican Academy of Dermatology suggests that
frequent users of tanning beds may become
addicted to these endorphins. Moreover,
blocking the effects of the endorphins could
lead to withdrawal symptoms. 
“This might explain why some people
appear to be hooked on sunbathing and
why frequent users of tanning beds say they
experience a positive mood change or are
more relaxed after a session,” says coauthor
Steven Feldman, a professor of dermatol-
ogy at Wake Forest University School of
Medicine. 
Feldman’s team thought that blocking
this endorphin rush might cause such peo-
ple to lose some of their tanning enthusi-
asm; what they didn’t expect was for some
to develop withdrawal symptoms.
The subjects included eight frequent
tanners (who used tanning beds 8 to 15
times per month) and eight infrequent tan-
ners (who used them up to 12 times per
year). The researchers administered either a
placebo or 5, 15, or 25 mg of naltrexone, a
central and peripheral opioid receptor
blocker; this blockage causes withdrawal
symptoms in opioid drug–addicted people
but not in nonaddicted people. The sub-
jects were then asked to lie for 10 minutes
on each of two tanning beds, one a true UV
bed, the other rigged not to deliver UV
light. Afterwards, the subjects, who were
blind to the test conditions, were asked to
describe which session made them feel best.
With the placebo and the 5-mg naltrex-
one dose, the frequent tanners showed a
clear preference for the UV bed—and more
strongly so than the infrequent tanners. But
this preference fell away with the 15- and
25-mg doses of naltrexone, “suggesting that
light-induced endorphins are reinforcing
[frequent tanners’] behavior,” says report
coauthor Mandeep Kaur, also a dermatol-
ogy professor at Wake Forest University
School of Medicine.
Further evidence of this was seen when
half of the frequent tanners developed nau-
sea and jitteriness with the 15-mg dose.
“These are common [opioid drug] with-
drawal symptoms,” explains Feldman, “and
they were bad enough for two subjects to
drop out.” Although there were no further
problems at the 25-mg dose, Feldman says
these results suggest that frequent tanners
suffer some degree of dependency on
endorphins. 
“Clearly tanning is not as addictive as
smoking,” remarks Robert Dellavalle, an
associate professor of dermatology at the
University of Colorado Health Sciences
Center. “Just look at the prevalence of
smoking in middle age—twenty percent in
the UK and the United States. In contrast,
there is a steep drop-off in the prevalence of
tanning as people age.”
Still, says, Feldman, although it’s not
time for the Drug Enforcement Admin-
istration to raid beauty parlors, “these results
do raise questions about the safe use of tan-
ning beds.” –Adrian Burton
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edited by Erin E. Dooley
RADIATION
Sun-sations. A new study shows why tanning bed rays feels so good to some people: UV light
produces endorphins to which frequent tanners may become addicted.Endometriosis and 
PCB Exposure
Endometriosis may be related to exposure to persistent pollutants
such as polychlorinated biphenyls (PCBs), according to research
published in the May 2006 issue of Chemosphere. This gynecological
disorder linked to infertility afflicts 10% of U.S. women of repro-
ductive age. Researchers measured blood PCB levels in women
undergoing laparoscopy for suspected endometriosis or other gyne-
cological conditions. Higher levels of PCBs were detected in women
with histologically confirmed endometriosis compared with controls. 
Toxicologist Elena De Felip of the Istituto Superiore di Sanità in
Rome and her colleagues measured 11 PCB congeners that are most
abundant in human tissue. In 80 women aged 20 to 40, the sum of
all congeners was 1.6 times higher in the 40 women diagnosed with
endometriosis than in controls. Three congeners, PCBs 138, 153,
and 180, were particularly higher in women with endometriosis.
These three congeners have been reported to have estrogenic activity
and to interfere with hormone-regulated processes. 
PCBs have been used since the 1930s, mainly in electrical equip-
ment. Although no longer manufactured, these persistent chemicals
accumulate in the food chain; today meat, fish, eggs, and milk are
chief sources of PCBs. But diet seems unable to explain the difference
in PCB levels detected in the two groups of women, since “the
dietary habits of the women were basically the same,” says De Felip.
De Felip suspects that differences in how women detoxify and
eliminate PCBs from the body may explain the disparity. These
processes are mediated by polymorphic enzymes; therefore, she says,
differences in toxicokinetic activity may represent the basis for the
higher concentrations detected in women with endometriosis and
may also be related to higher or lower susceptibility to that condition. 
Studies of PCBs and endometriosis face several limitations.
Researchers typically measure only a few widespread congeners that
are selected because of their toxicological activities, including an asso-
ciation with cancer shown in animal models. “So we’re only getting
part of the picture,” says Germaine Buck Louis, chief of the
Epidemiology Branch at the National Institute of Child Health and
Human Development. 
In a study described in the January 2005 issue of Human Repro-
duction, Buck’s team measured 62 congeners in 84 women undergo-
ing laparoscopy. Levels of 4 antiestrogenic congeners were 3.77 times
higher in women diagnosed with endometriosis than in controls.
“We don’t fully understand the role of estrogenic and antiestrogenic
PCBs,” she says, but complex interactions of many PCBs as well as
other chemicals may be involved in developing endometriosis. 
Recent advances in PCB detection methods allow more con-
geners to be measured at lower concentrations. “Women with
endometriosis may have low levels of a particular congener not found
in [other women],” says Louis. Moreover, breastfeeding reduces PCB
levels in women, so women without endometriosis may have lower
blood levels because they become pregnant and breastfeed more
often. “There’s no ideal comparison group for endometriosis stud-
ies,” says Louis, and “there are no easy answers.” –Carol Potera
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No Dental Dilemma
for BPA
Among the many uses of bisphenol A
(BPA) is the manufacture of resin-based
dental composites and sealants. Recently a
team of researchers from the CDC sank
their teeth into questions about whether
BPA monomer leaching from sealants
could be harmful to people. The results of
their human study, presented in the
March 2006 issue of the Journal of
the American Dental Association, sug-
gest that although leaching does
occur, sealants are still a safe means
of preventing dental cavities.
Low-level exposures to BPA
monomer in pregnant rodents, at a
level that humans could potentially
receive from dental sealants, have
been shown to disrupt reproductive
development in their fetuses, and
concerns have emerged about the
possibility of human health effects
from dental exposures. Scientific ex-
ploration of this question has yielded
inconsistent results, says Renée Joskow,
first author of the March paper.
Much of this is due to limitations in
laboratory detection and translation of ani-
mal studies to human health effects, as well
as insufficiently addressing the parameters of
exposure in a clinical dental setting. 
The CDC team, led by Joskow (now of
the U.S. Public Health Service) and Dana
Barr, looked at 14 nonsmokers receiving
their first resin-based sealants as part of their
routine dental care. Each subject received
one of two brands of dental sealant manu-
factured by two well-established dental
equipment and material supply firms. Then
their saliva and urine were tested for BPA. 
All the patients had BPA in their saliva
and urine, even before treatment. For
patients receiving Helioseal F sealants, saliva
BPA doubled immediately after treatment
and returned to baseline within 1 hour.
Urine BPA more than tripled 1 hour after
treatment and returned to baseline within
24 hours. For patients receiving Delton LC
sealants, saliva BPA increased nearly 126
times immediately after application and was
still 23 times higher after 1 hour. Urine BPA
jumped 10 times 1 hour after treatment and
was still elevated 24 hours later. Both levels
eventually returned to baseline. 
Barr believes the patients’ baseline
BPA came from background exposures
from environmental sources such as
water and food packaging. These, she
suggests, could be “a more chronic low-
level source of exposure” than dental
sealants. Barr adds that in her view,
although point-source exposure from
dental sealants might approach levels
that induce health effects in rodents,
“[it] is not the most significant source
of exposure in humans.” Moreover, she
holds that exposure to BPA from den-
tal sealants, already variable and short-
lived in the body, could be easily
reduced further by having the patient
spit frequently in the hours after
application. –Julian Josephson
WOMEN’S HEALTH
CHEMICAL EXPOSURES
BPAhhh. New data show that exposure to bisphenol A in den-
tal sealants is likely an insignificant source of risk.T
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Unlimited Mileage from the
Drive-Thru?
A company offering rental cars powered entirely by
biodiesel opened its doors in Los Angeles in
February 2006. The cars get 400 to 800 miles per
tank on 100% biodiesel made from recycled
cooking oil. Bio-Beetle Eco Rental Cars first started
in Hawaii in 2003 with a single car, and now offers
16 at that location, while the LA location is starting
with 4 vehicles. Company founder Shaun Stenshol
hopes to open two more U.S. locations by the end
of the year. Other biodiesel rentals may not be far
behind: Enterprise is pilot-testing an offering of
biodiesel Jeeps in Portland, Oregon.
Goldman Environmental
Prize 2006
For 17 years, the $125,000 Goldman Environmental
Prize has been awarded to activists dedicated to
effecting environmental change in their home
countries. The six winners for 2006 are:
•  Yu Xiaogang, of China, who created
groundbreaking watershed management programs
while documenting the socioeconomic impact of
dams on Chinese communities. China’s central
government now considers social impact
assessments for major dam developments.
•  Anne Kajir, of Papua New Guinea, who
uncovered government corruption that allowed
rampant illegal logging of the region’s largest
remaining intact parcel of tropical rain forest. As a
novice lawyer, she successfully defended a Supreme
Court appeal forcing the logging industry to pay
damages to indigenous land owners.
•  Tarcísio Feitosa da Silva, of Brazil, who led
efforts to create the world’s largest area of
protected tropical forest regions in a remote area
of northern Brazil that was threatened by illegal
logging. 
•  Craig E. Williams, of Kentucky, who convinced
the Pentagon to halt plans for burning old chemical
weapons that had been stockpiled around the
United States. 
•  Olya Melen, of Ukraine, who used the legal
system to temporarily halt the construction of a
massive canal through the rich wetlands of the
Danube Delta. 
•  Silas Kpanan’Ayoung Siakor, of Liberia, who
revealed evidence that former Liberian president
Charles Taylor used profits from unchecked logging
to pay for a 14-year civil war. The revelation led the
UN Security Council to ban the export of Liberian
timber, part of wider ongoing trade sanctions.
Cure Autism Now ehpnet
In 1995, parents of children with autism joined together to form the
nonprofit organization Cure Autism Now (CAN). Since then, its mem-
bership has grown to include clinicians and scientists committed to
accelerating the pace of biomedical research in autism. CAN raises
and distributes funds for research on the causes, prevention, and
treatment of autism, as well as education and outreach. As a
resource for everyone interested its work, CAN has a website located
at http://www.cureautismnow.org/. 
So far, CAN has committed over $25 million to research funding
and has established and continues to support the Autism Genetic
Resource Exchange (AGRE). Clicking on the Research link at the top of
the CAN homepage takes visitors to an overview of the CAN science
program, which includes six initiatives that the group believes will yield
the most effective treatment for individuals with autism. 
The Genomics Initiative focuses on gene mapping and microarray
work. CAN’s goal is to identify several genes involved in autism with-
in the next three years. Closely related to the Genomics Initiative is
the AGRE, an open gene bank with a large collection of immortal-
ized cell lines and DNA samples
gathered from families with
more than one autistic child.
Available on the AGRE page is a
link to research updates pub-
lished since 2001.
The goal of the Innovative
Technology for Autism Initiative
is to stimulate development of
products that provide realistic
solutions to the issues encoun-
tered by those with autism,
their families, educators, health
care specialists, and researchers.
The initiative offers multiyear grants, fast-track “bridge” grants, and
educational programs. It also sponsors a workgroup within which
investigators can meet, share, and collaborate, and which also serves
to actively bring new investigators into the field. 
One major hurdle that autism researchers are working to overcome
is the lack of any biomarker for diagnosis. The CAN Biomarkers
Initiative has yielded two preliminary findings of possible autism bio-
markers—one a novel protein in the urine of children with autism and
some of their unaffected relatives, and the other a distinct lipid profile
that was seen in 20 AGRE samples. CAN has launched a study in an
effort to replicate and confirm these results.
In the past few years, new findings on neuroplasticity, the ability of
the brain to grow and change throughout life, have led to significant
breakthroughs in the treatment of stroke and dyslexia through a
process called neural retraining. To apply these same ideas to the treat-
ment of autism, CAN has established the Neural Retraining Initiative.
The initiative’s first project, led by Michael Merzenich of the University
of California, San Francisco, is working to design, produce, and test
nonpharmaceutical tools and techniques, including one to prevent the
emergence of full-blown autism in at-risk infants. 
CAN has also awarded several grants through its Environmental
Factors in Autism initiative to study the neurotoxicity of mercury and
how it may factor in the development of autism. Thimerosal, which
contains ethylmercury, has been widely used as a preservative in vac-
cines and other health and medical products, and has been raised as a
potential contributor to autism. –Erin E. Dooley